PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Eli Lilly and Company, Indianapolis, IN, USA. knorr_john_sharp@lilly.com.\', \'Eli Lilly and Company, Indianapolis, IN, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-021-05699-3
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 34674750
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Innovative clinical trial design and delivery: a phase 3 COVID-19 post-exposure prophylaxis study in skilled nursing and assisted living facilities (BLAZE-2).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all